JLab core review committee and JLab expert consultant (JPal) (2015-2022)
Expert Consultant, Board of Science and Technology, Executive Yuan, Taiwan, R.O.C (2016-2020)
Committee member of the working group for miRNA standardization, Standards Development Organization, Singapore Manufacturing Federation, sponsored by Health Sciences Authority (2020)
Distinguished Alumni, National Tsing-Hua Univ. Taiwan (2015)
US NIH/NCI grant review committee for RFA-CA-13-015 “Cancer Detection, Diagnostics, and Treatment Technologies for Global Health (UH2/UH3)”, NIH, US (2014)
Scientific Advisory Council, Genetic Analysis, Life Technologies (known today as ThermoFisher Scientific) (2012-2014)
Awards
Received 3 J&J Leadership awards 2022
J&J “Ovation” Leadership Award (received $6000): “2021 PH DAS Renewal & Expansion Strategy”
Received 8 consecutive J&J Leadership Imperative “Applause” awards (awarded $1500 each) as core committee for Janssen Global Scientific Awards Review Committee, 2015-2022
J&J Leadership “Ovation” Award (awarded 3% base salary): Shape “Dx strategies”, 2018
Novartis: “2011 NIBR Team Award” for excellent science and teamwork on Everolimus (awarded $1000)
Received 4 Novartis Awards for oncology CDX programs and due diligence effort for M&A (2011)
Chiron: “Contribution Award” for successful regulatory filing and approval of Ultrio for HIV/HCV/HBV blood screening (2006); “Outstanding Performance” for exceeding program timelines (2005), “Inventor Recognition Award” (2004); “Outstanding Efforts” for accelerated HCV E1E2 vaccine Phase I/II IND (2001); “Exception Award” with $6500 for successful UK MCA filing and approval of Menjugate vaccine (1999).
